Skip Navigation
ChemIDplus A TOXNET DATABASE LiteBrowseAdvanced

Substance Name: Aluminum flufenamate [JAN]
RN: 16449-54-0
UNII: 9NZ7H8YAHG
InChIKey: OSQHGAXCVAYZPZ-UHFFFAOYSA-K

Classification Codes

  • Drug / Therapeutic Agent
  • Reproductive Effect

Molecular Formulas

  • C14-H9-F3-N-O2.1/3Al
  • C42-H27-Al-F9-N3-O6

Molecular Weight

  • 867.654
 
* denotes mobile formatted website

Links to Resources


Search for this InChIKey on the Web

Names and Synonyms

Name of Substance

  • Aluminum flufenamate
  • Aluminum flufenamate [JAN]

Synonyms

  • Alfenamin
  • Alufenamine
  • Aluminium flufenamate
  • Aluminum flufenamate
  • Aluminum, tris(2-((3-(trifluoromethyl)phenyl)amino)benzoato-N,O)-
  • EINECS 240-498-9
  • Flufenamic acid, aluminium salt
  • Opyrin
  • Tris(N-(alpha,alpha,alpha-trifluoro-m-tolyl)anthranilato)aluminum
  • TS 1801
  • UNII-9NZ7H8YAHG

Systematic Names

  • Aluminum N-(3'-trifluoromethylpheny)anthranilate
  • Aluminum, tris(N-(alpha,alpha,alpha-trifluoro-m-tolyl)anthranilato)-
  • Tris(2-((3-(trifluoromethyl)phenyl)amino)benzoato-N,O)aluminium

Registry Numbers

CAS Registry Number

  • 16449-54-0

FDA UNII

  • 9NZ7H8YAHG

System Generated Number

  • 0016449540

Molecular Formulas

Molecular Formulas

  • C14-H9-F3-N-O2.1/3Al
  • C42-H27-Al-F9-N3-O6

Molecular Formula Fragments

  • Al
  • C14-H9-F3-N-O2
  • COMPONENT

Structure Descriptors

InChI

1S/3C14H10F3NO2.Al/c3*15-14(16,17)9-4-3-5-10(8-9)18-12-7-2-1-6-11(12)13(19)20;/h3*1-8,18H,(H,19,20);/q;;;+3/p-3

InChIKey

OSQHGAXCVAYZPZ-UHFFFAOYSA-K

Smiles

c1(c(Nc2cc(C(F)(F)F)ccc2)cccc1)C([O-])=O.[O-]C(c1c(Nc2cc(ccc2)C(F)(F)F)cccc1)=O.[O-]C(c1c(Nc2cc(ccc2)C(F)(F)F)cccc1)=O.[Al+3]

Toxicity

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
mouse LD50 intraperitoneal 1560mg/kg (1560mg/kg) LUNGS, THORAX, OR RESPIRATION: CHRONIC PULMONARY EDEMA

BEHAVIORAL: ATAXIA

BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)
Toho Igakkai Zasshi. Journal of Medical Society of Toho University. Vol. 17, Pg. 153, 1970.
mouse LD50 oral 1460mg/kg (1460mg/kg) LUNGS, THORAX, OR RESPIRATION: CHRONIC PULMONARY EDEMA

BEHAVIORAL: ATAXIA

BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)
Toho Igakkai Zasshi. Journal of Medical Society of Toho University. Vol. 17, Pg. 153, 1970.
mouse LD50 subcutaneous > 1400mg/kg (1400mg/kg) BEHAVIORAL: ATAXIA

SKIN AND APPENDAGES (SKIN): HAIR: OTHER

BEHAVIORAL: SOMNOLENCE (GENERAL DEPRESSED ACTIVITY)
Toho Igakkai Zasshi. Journal of Medical Society of Toho University. Vol. 17, Pg. 153, 1970.
rat LD50 intraperitoneal 420mg/kg (420mg/kg) BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

LUNGS, THORAX, OR RESPIRATION: DYSPNEA
Toho Igakkai Zasshi. Journal of Medical Society of Toho University. Vol. 17, Pg. 153, 1970.
rat LD50 oral 550mg/kg (550mg/kg) LUNGS, THORAX, OR RESPIRATION: DYSPNEA

BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)
Toho Igakkai Zasshi. Journal of Medical Society of Toho University. Vol. 17, Pg. 153, 1970.
rat LD50 subcutaneous 725mg/kg (725mg/kg) BEHAVIORAL: ALTERED SLEEP TIME (INCLUDING CHANGE IN RIGHTING REFLEX)

LUNGS, THORAX, OR RESPIRATION: DYSPNEA
Toho Igakkai Zasshi. Journal of Medical Society of Toho University. Vol. 17, Pg. 153, 1970.